Hepatology News, Info, Symptoms

* Hepatology101 SEARCH *

*Filter: "Gall-Stone"

Gallstones - Symptoms & causes - Mayo Clinic
Some people develop just one gallstone, while others develop many gallstones at the same time. People who experience symptoms from their gallstones usually require gallbladder removal surgery. Gallstones that don't cause any signs and symptoms typically don't need treatment.

Gallstones (Cholelithiasis): Symptoms, Causes & Treatment
Gallstones (cholelithiasis) are hardened pieces of bile that form in your gallbladder or bile ducts. They’re common, especially in females. Gallstones don’t always cause problems, but they can if they get stuck in your biliary tract and block your bile flow.

Gallstones (Cholelithiasis): Symptoms, Causes, and Treatments
Gallstones are pieces of solid material that form in your gallbladder, a small organ under your liver. If you have gallstones, you might hear your doctor say you have cholelithiasis. Your...

Gallstone - Wikipedia
A gallstone is a stone formed within the gallbladder from precipitated bile components. [2] The term cholelithiasis may refer to the presence of gallstones or to any disease caused by gallstones, [5] and choledocholithiasis refers to the presence of migrated gallstones within bile ducts.

Gallstones: Causes, Symptoms, Diagnosis, and Treatment
Gallstones are more than just small, pebble-like formations inside the body—they can be silent passengers in the gallbladder, or they can become painful, life-disrupting intruders. For some people, gallstones remain hidden, discovered only incidentally during scans for unrelated conditions.

Gallstones - Diagnosis & treatment - Mayo Clinic
Your doctor may recommend that you be alert for symptoms of gallstone complications, such as intensifying pain in your upper right abdomen. If gallstone signs and symptoms occur in the future, you can have treatment.

Gallstones: Symptoms, Causes, Treatment, and More - Healthline
Gallbladder issues typically occur when something is blocking the bile duct opening in the gallbladder. Gallstones are formed when substances found in bile, such as bilirubin and cholesterol,...

Dissolving Gallstones Without Surgery: What Works? - Verywell Health
Gallstones are lumps that form in the gallbladder when stored bile crystallizes. There are no proven home remedies to dissolve gallstones, but some medicines can dissolve small cholesterol stones. Dietary changes, exercise, and weight management may help prevent more gallstones.

Gallstones - NHS
Gallstones are small stones that form in the gallbladder. Most people who have them do not get symptoms. If gallstones are causing pain in your tummy, you may need surgery to remove your gallbladder. The gallbladder is a small organ in the top part of your tummy that helps you digest your food.

How to Get Rid of Gallstones: 9 Natural Treatments - Healthline
Gallstones are hard deposits that form in your gallbladder. There are two types of gallstones: Surgery is a common treatment for gallstones, but you may be able to treat them with natural...

* Hepatology101 LATEST NEWS *

                    *Filter: "Gall-Stone"

Indian Literature Review on Gallstones : Gastroenterology, Hepatology and Endoscopy Practice  ovid.com
Pediatric gallstone disease—Management difficulties in clinical practice  www.elsevier.com
Gallstones formed by NETs  Nature
Gallstones May Be the First Sign of Fatty Liver Disease  Verywell Health
Childhood Obesity Is Making Gallstones More Common  Cleveland Clinic
Non-Surgical Management of Gallstones During Pregnancy: A Clinical Case Report  Cureus
Progression from Asymptomatic to Symptomatic Gallstones: The Risk Factors  Gastroenterology Advisor
Unusual ivory-white gallstones identified during indocyanine green fluorescence-guided laparoscopic cholecystectomy: a rare case report  Frontiers
Statins affect gallstone diseases: Underlying mechanism(s) are to be established  Wiley Online Library
The association between life’s essential 8 and gallstones: A cross-sectional study  Nature
From lipid secretion to cholesterol crystallization in bile. Relevance in cholesterol gallstone disease  www.elsevier.com
Association Between Type I and II Diabetes With Gallbladder Stone Disease  Frontiers
EUS-Guided Gall Bladder Drainage in Surgically Unfit Patients Presenting with Acute Cholecystitis  Cleveland Clinic
Relationship of triglyceride-glucose index to gallstone prevalence and age at first gallstone surgery in American adults  Nature
Thoracic empyema due to migrated gallstones  www.elsevier.com

Common Hepatology Symptoms

Jaundice (Icterus) — Yellowing of the skin and sclera caused by elevated serum bilirubin levels due to impaired hepatic processing or biliary obstruction.

Ascites — Pathologic accumulation of fluid in the peritoneal cavity, commonly secondary to portal hypertension and advanced liver cirrhosis.

Hepatic Encephalopathy — Spectrum of neuropsychiatric abnormalities including confusion, asterixis, and altered consciousness resulting from neurotoxin accumulation.

Pruritus — Severe, generalized skin itching frequently associated with cholestatic liver diseases and systemic bile acid accumulation.

Right Upper Quadrant Abdominal Pain — Dull ache or sensation of fullness caused by stretching of Glisson's capsule surrounding an enlarged or inflamed liver.

Spider Angiomas and Palmar ErytHepa — Vascular cutaneous signs stemming from altered sex hormone metabolism and hyperdynamic circulation in chronic liver disease.

Dark Urine and Acholic Stools — Tea-colored urine from bilirubinuria paired with pale, clay-colored stools indicating impaired biliary drainage.

Milestones in Hepatology History

Discovery of the Australia Antigen (1965) — Baruch Blumberg identified the surface antigen of Hepatitis B, paving the way for diagnostic screening and the first HBV vaccine.

First Successful Human Liver Transplant (1967) — Dr. Thomas Starzl performed the world's first successful human liver transplantation at the University of Colorado Health Sciences Center.

Identification of Hepatitis Delta Virus (1977) — Mario Rizzetto discovered the delta antigen, characterizing HDV as a defective subviral pathogen reliant on HBV co-infection.

Cloning and Identification of Hepatitis C (1989) — Michael Houghton, Harvey Alter, and Charles Rice isolated the non-A, non-B hepatitis virus, officially naming it Hepatitis C.

Introduction of MELD Score System (2002) — The Model for End-Stage Liver Disease was adopted in the United States to prioritize liver allocation based on 3-month mortality risk.

Approval of Direct-Acting Antivirals for HCV (2013) — The FDA approved Sofosbuvir, ushering in an era of highly effective, interferon-free oral curative regimens for chronic Hepatitis C.

Nomenclature Shift to MASLD and MASH (2023) — Global liver societies renamed NAFLD/NASH to better reflect underlying metabolic pathology and eliminate stigmatizing language.

Current Hepatology Research

Bepirovirsen Functional Cure Trials — Evaluating antisense oligonucleotides to achieve a sustained loss of HBsAg and drug-free clinical response in patients living with chronic hepatitis B.

MASLD Diagnostics and Screening — Refining non-invasive biomarker panels and metabolic criteria to detect metabolic dysfunction-associated steatotic liver disease early in co-infected populations.

Hepatitis D Expanded Testing Protocols — Implementing reflexive antibody and RNA testing strategies to address global underdiagnosis of delta hepatitis co-infections.

Global Elimination Strategy Implementation — Tracking regional epidemiological data and public health interventions designed to accelerate viral hepatitis eradication goals.

RNA Interference (RNAi) Gene Silencing — Investigating small interfering RNA therapies to knock down viral transcripts and reduce antigen production in chronic liver infections.

MASH Fibrosis Biomarker Development — Validating novel serum panels and elastography metrics to monitor metabolic dysfunction-associated steatohepatitis regression without invasive biopsies.

In Vivo Gene Editing via Lipid Nanoparticles — Utilizing hepatic-targeted LNP delivery systems to correct monogenic metabolic liver disorders directly within host hepatocytes.

Gut Microbiome Alterations in Cirrhosis — Analyzing gut-liver axis dysbiosis to prevent bacterial translocation and manage portal hypertension complications in end-stage liver disease.